Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.050
-0.060 (-1.93%)
Dec 20, 2024, 4:00 PM EST - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $404.36 million as of December 20, 2024. Its market cap has increased by 9.59% in one year.
Market Cap
404.36M
Enterprise Value
417.69M
1-Year Change
9.59%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $404.36M, a decrease of -67.29%. That is a compound annual growth rate of -17.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 404.36M | -24.71% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | 961.60M | 92.71% |
| Dec 31, 2019 | 499.00M | -59.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGM Biosciences | 410.30M |
| Aura Biosciences | 409.60M |
| Korro Bio | 409.11M |
| Tactile Systems Technology | 407.95M |
| Personalis | 406.23M |
| National Research | 403.08M |
| Quanterix | 402.98M |
| Akebia Therapeutics | 399.27M |